NMO-IgG in the diagnosis of neuromyelitis optica.

NMO-IgG in the diagnosis of neuromyelitis optica.

Dettagli Bibliografici
Autori principali:	Jarius, S, Franciotta, D, Bergamaschi, R, Wright, H, Littleton, E, Palace, J, Hohlfeld, R, Vincent, A
Natura:	Journal article
Lingua:	English
Pubblicazione:	2007

Documenti analoghi

Revised diagnostic criteria for neuromyelitis optica--incorporation of NMO-IgG status.
di: Jarius, S, et al.
Pubblicazione: (2007)

An audit of the diagnostic usefulness of the NMO-IgG assay for neuromyelitis optica
di: Littleton, E, et al.
Pubblicazione: (2006)

Frequency of Aqp4-Ab in patients with neuromyelitis optica (Devic's syndrome) is higher than predicted by NMO-IgG testing
di: Jarius, S, et al.
Pubblicazione: (2007)

Devic's neuromyelitis optica: Prognostic implications of NMO IgG status in Turkish patients
di: Akman-Demir, G, et al.
Pubblicazione: (2008)

Seroprevalence of NMO-IgG antibody in Brazilian patients with neuromyelitis optica Soroprevalência do anticorpo NMO-IgG em pacientes brasileiros com neuromielite óptica
di: Tarso Adoni, et al.
Pubblicazione: (2008-06-01)

A novel sensitive assay for aqueporin-4 antibodies (NMO-IgG)
di: Waters, P, et al.
Pubblicazione: (2007)

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
di: Paul, F, et al.
Pubblicazione: (2007)

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
di: Friedemann Paul, et al.
Pubblicazione: (2007-04-01)

Cytotoxic edema in a patient with neuromyelitis optica: This may be suggestive of various pathogenic roles of NMO-IgG
di: Min, J, et al.
Pubblicazione: (2010)

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?
di: Downer, J, et al.
Pubblicazione: (2012)

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: Is MRI obsolete?
di: Downer, J, et al.
Pubblicazione: (2012)

Seroprevalence of NMO-IgG Antibody in Neuromyelitis optica (NMO) and Its Specificity in Differentiating NMO from Other Demyelinating Diseases with Overlap Symptoms: An Iranian Experience
di: Mohammad Hossein Harirchian, et al.
Pubblicazione: (2015-02-01)

LONG TERM OUTCOME IN NEUROMYELITIS OPTICA: LESSONS FROM 6 YEARS OF THE UK NMO STUDY
di: Jacob, A, et al.
Pubblicazione: (2009)

NMO-IgG/Aqp4-Ab belongs to the IgG1 subclass and activates complement in vitro
di: Jarius, S, et al.
Pubblicazione: (2007)

Neuromyelitis Optica (NMO) — Study Review
di: Justyna Chojdak-Łukasiewicz
Pubblicazione: (2021-06-01)

Neuromyelitis Optica with NMO-IgG/ Anti-AQP4 Antibody Positive: First Case Reported from Uttarakhand India
di: Manish Mittal, et al.
Pubblicazione: (2014-07-01)

Autoimmune thyroiditis associated with neuromyelitis optica (NMO)
di: Sudulagunta, Sreenivasa Rao, et al.
Pubblicazione: (2015-11-01)

Changes in B and T-cell subsets and NMO-IgG/AQP-4 levels after immunoglobulins and rituximab treatment for an acute attack of neuromyelitis optica
di: C. de Andrés, et al.
Pubblicazione: (2015-06-01)

Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
di: Jarius, S, et al.
Pubblicazione: (2008)

IgG subclasses of disease-specific antibodies and complement activation in vitro in myasthenia gravis and neuromyelitis optica
di: Jacob, S, et al.
Pubblicazione: (2007)

NMO-DBr: the Brazilian Neuromyelitis Optica Database System
di: Marco A. Lana-Peixoto, et al.
Pubblicazione: (2011-08-01)

Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.
di: Waters, P, et al.
Pubblicazione: (2012)

Neuromyelitis optica IgG causes placental inflammation and fetal death.
di: Saadoun, S, et al.
Pubblicazione: (2013)

Seroprevalence of Neuromyelitis Optica-IgG of Childhood Compared to Adults
di: J Gordon Millichap
Pubblicazione: (2008-02-01)

Neuromyelitis optica and longitudinally extensive transverse myelitis following thymectomy for myasthenia gravis
di: Jarius, S, et al.
Pubblicazione: (2007)

Neuromyelitis optica-IgG testing in an Indian cohort with neuromyelitis optica and related demyelinating disorders: Our experience
di: Narayanan Unni, et al.
Pubblicazione: (2013-01-01)

Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes
di: Juryńczyk, M, et al.
Pubblicazione: (2015)

Neuromyelitis optica IgG causes placental inflammation and fetal death in mice
di: Saadoun, S, et al.
Pubblicazione: (2013)

Plasmablasts as migratory IgG-producing cells in the pathogenesis of neuromyelitis optica.
di: Norio Chihara, et al.
Pubblicazione: (2013-01-01)

Effect of IgG from seronegative and seropositive neuromyelitis optica patients on mouse brain
di: Saadoun, S, et al.
Pubblicazione: (2013)

Cerebrospinal fluid/serum gradient of IgG is associated with disability at acute attacks of neuromyelitis optica.
di: Kim, S, et al.
Pubblicazione: (2011)

Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica.
di: Jarius, S, et al.
Pubblicazione: (2008)

Cytoprotective IgG antibodies in sera from a subset of patients with AQP4-IgG seropositive neuromyelitis optica spectrum disorder
di: Lukmanee Tradtrantip, et al.
Pubblicazione: (2021-11-01)

MOG-IGG IN NMO AND NMO-LIKE DISORDERS
di: Luppe, S, et al.
Pubblicazione: (2014)

Differences in Advanced Magnetic Resonance Imaging in MOG-IgG and AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorders: A Comparative Study
di: Felix A. Schmidt, et al.
Pubblicazione: (2020-09-01)

Neuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4.
di: Jarius, S, et al.
Pubblicazione: (2008)

Clinical spectrum associated with aquaporin-4 antibodies (NMO-IgG)
di: Y. Blanco, et al.
Pubblicazione: (2010-01-01)

Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.
di: Waters, P, et al.
Pubblicazione: (2008)

Neutrophil protease inhibition reduces NMO-IgG-induced damage in mouse brain
di: Papadopoulos, M, et al.
Pubblicazione: (2011)

Complement-dependent bystander injury to neurons in AQP4-IgG seropositive neuromyelitis optica
di: Tianjiao Duan, et al.
Pubblicazione: (2018-10-01)